THREE-YEAR ANALYSIS OF THE DALIAH TRIAL - A RANDOMIZED CONTROLLED PHASE III CLINICAL TRIAL COMPARING RECOMBINANT INTERFERON ALPHA-2 VS. HYDROXYUREA IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS

Trine Alma Knudsen (Lecturer), Lund Hansen, D. (Other), Lucas Frans Ocias (Other), Weiss Bjerrum, O. (Other), Brabrand, M. (Other), Christina Ellervik (Other), Daniel el Fassi (Other), Frederiksen, M. (Other), Lasse Kjær (Other), Thomas Kielsgaard Kristensen (Other), Kruse, T. A. (Guest lecturer), Hans Torben Mourits-Andersen (Other), Peter Møller (Other), Ulrik Malthe Overgaard (Other), Dustin Andersen Patel (Other), Marianne Tang Severinsen (Other), Vibe Skov (Other), Anders Lindholm Sørensen (Other), Stentoft Jesper (Other), Jørn Starklint (Other), Karin de Stricker (Other), Thomassen, M. (Other), Larsen, T. S. (Guest lecturer), C Hasselbalc Hans (Other)

Activity: Talks and presentationsConference presentations

Period16. Jun 2019
Event typeConference
LocationAmsterdam, Netherlands
Degree of RecognitionInternational